Article
A sensitive mutation screening method supporting cell line development for biotherapeutics.
Analytical biochemistry - 15 Jul 2016
Valisheva Ildana, Harris Reed J, Zhu-Shimoni Judith
Abstract excerpt
Random genetic mutations, which can occur during cell line development, can lead to sequence variants that comprise pharmaceutical product quality generated by recombinant technology. Mutation screening can minimize the probability of selecting clones harboring sequence variants. Here we report a polymerase chain reaction (PCR)-based mutation screening approach using high-resolution melting (HRM) analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
